Isomorphic Labs raised $5 billion to expand its AI drug design platform and move its first drug candidates toward human trials after a $2.1 billion May round.
AI drug discovery startup Isomorphic Labs raises record $5 billion. Image: Isomorphic
AI has already learned to predict how proteins fold. Now Isomorphic Labs wants to turn that knowledge into medicines, and investors are putting $5 billion behind the idea.
The Alphabet-backed company announced a $5 billion Series C funding round on Nov. 17, co-led by Greenoaks and Sequoia Capital. Andreessen Horowitz (a16z) and several other new investors joined, while Alphabet and all existing investors…
Read the full article at TECHREPUBLIC.COM









